[1] Rubin LJ. Pulmonary arterial hypertension[J]. Proc Am Thorac Soc, 2006, 3(1):111-115. [2] Montani D, Günther S, Dorfmüller P, et al. Pulmonary arterial hyper tension[J]. Orphanet J Rare Dis, 2013, 8(1):97-124. [3] Seferian A, Simonneau G. Therapies for pulmonary arterial hypertension:where are we today, where do we go tomorrow?[J]. Eur Respir Rev, 2013, 22(129):217-226. [4] Levarge BL. Prostanoid therapies in the management of pulmonary arterial hypertension[J]. Ther Clin Risk Manag, 2015, 11:535-547. [5] Kanda T, Akiyama H, Yanagida A, et al. Inhibitory effects of apple polyphenol on induced histamine release from RBL-2H3 cells and rat mast cells[J]. Bio sci Biotechnol Biochem, 1998, 62(7):1284-1289. [6] Schermuly RT, Ghofrani HA, Wilkins MR, et al. Mechanisms of disease:pulmonary arterial hypertension[J]. Nat Rev Cardiol, 2011, 8(8):443-455. [7] Tuder RM, Marecki JC, Richter A, et al. Pathology of pulmonary hypertension[J]. Clin Chest Med, 2007, 28(1):23-42. [8] 骆健峰, 吴小脉, 范小芳, 等. NO和HIF-1α在大鼠低氧性肺动脉高压中的作用及相互关系[J]. 中国应用生理学杂志, 2006, 22(04):488-491. [9] Guo Q, Xu H, Yang X, et al. Notch activation of Ca2+-sensing receptor mediates hypoxia-induced pulmonary hypertension[J]. Hypertens Res, 2017, 40(2):117-129. [10] Smith KA, Ayon RJ, Tang H, et al. Calcium-sensing receptor regulates cytosolic[Ca2+] and plays a major role in the development of pulmonary hypertension[J]. Front Physiol, 2016, 7:517-523. [11] Peng X, Li HX, Shao HJ, et al. Involvement of calcium-sensing receptors in hypoxia-induced vascular remodeling and pulmonary hypertension by promoting phen o typic modulation of small pulmonary arteries[J]. Mol Cell Biochem, 2014, 396(1-2):87-98. [12] Wang R, Xu C, Zhao W, et al. Calcium and polyamine regulated calcium-sensing receptors in cardiac tissues[J]. Eur J Biochem, 2003, 270(12):2680-2688. |